Davivienda deal
BNS Stock Surges Near 52-Week High After Q4 2025 Earnings Beat and Davivienda Deal: Is Scotiabank Still a Buy?
Bank of Nova Scotia (BNS) stock trades at record highs after a robust Q4 2025 earnings beat and the strategic Davivienda deal. Investors now weigh premium valuations against growth prospects and risks as Scotiabank reshapes its international strategy.